CO2022010461A2 - Composición para usar en el tratamiento de trastornos cognitivos - Google Patents
Composición para usar en el tratamiento de trastornos cognitivosInfo
- Publication number
- CO2022010461A2 CO2022010461A2 CONC2022/0010461A CO2022010461A CO2022010461A2 CO 2022010461 A2 CO2022010461 A2 CO 2022010461A2 CO 2022010461 A CO2022010461 A CO 2022010461A CO 2022010461 A2 CO2022010461 A2 CO 2022010461A2
- Authority
- CO
- Colombia
- Prior art keywords
- treatment
- cognitive disorders
- composition
- compositions
- contain
- Prior art date
Links
- 208000010877 cognitive disease Diseases 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 3
- 239000000284 extract Substances 0.000 abstract 2
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 abstract 1
- DSCFFEYYQKSRSV-UHFFFAOYSA-N 1L-O1-methyl-muco-inositol Natural products COC1C(O)C(O)C(O)C(O)C1O DSCFFEYYQKSRSV-UHFFFAOYSA-N 0.000 abstract 1
- VJXUJFAZXQOXMJ-UHFFFAOYSA-N D-1-O-Methyl-muco-inositol Natural products CC12C(OC)(C)OC(C)(C)C2CC(=O)C(C23OC2C(=O)O2)(C)C1CCC3(C)C2C=1C=COC=1 VJXUJFAZXQOXMJ-UHFFFAOYSA-N 0.000 abstract 1
- DSCFFEYYQKSRSV-KLJZZCKASA-N D-pinitol Chemical compound CO[C@@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@H]1O DSCFFEYYQKSRSV-KLJZZCKASA-N 0.000 abstract 1
- DSCFFEYYQKSRSV-HMSOCMLXSA-N D-pinitol Natural products CO[C@H]1[C@@H](O)[C@@H](O)[C@@H](O)[C@H](O)[C@H]1O DSCFFEYYQKSRSV-HMSOCMLXSA-N 0.000 abstract 1
- 235000008100 Ginkgo biloba Nutrition 0.000 abstract 1
- 244000194101 Ginkgo biloba Species 0.000 abstract 1
- 229940096998 ursolic acid Drugs 0.000 abstract 1
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/745—Polymers of hydrocarbons
- A61K31/75—Polymers of hydrocarbons of ethene
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/60—Fish, e.g. seahorses; Fish eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/322—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the nervous system or on mental function
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/18—Lipids
- A23V2250/186—Fatty acids
- A23V2250/1868—Docosahexaenoic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Psychiatry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Marine Sciences & Fisheries (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES2020070005 | 2020-01-03 | ||
| PCT/EP2021/050270 WO2021136848A1 (fr) | 2020-01-03 | 2021-01-08 | Composition destinée à être utilisée dans le traitement de troubles cognitifs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO2022010461A2 true CO2022010461A2 (es) | 2022-08-09 |
Family
ID=69941402
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CONC2022/0010461A CO2022010461A2 (es) | 2020-01-03 | 2022-07-26 | Composición para usar en el tratamiento de trastornos cognitivos |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP4084787A1 (fr) |
| JP (1) | JP7655920B2 (fr) |
| KR (1) | KR20220123272A (fr) |
| CN (1) | CN115066237A (fr) |
| AU (1) | AU2021204964A1 (fr) |
| BR (1) | BR112022013296A2 (fr) |
| CO (1) | CO2022010461A2 (fr) |
| MX (1) | MX2022008258A (fr) |
| WO (1) | WO2021136848A1 (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115944729A (zh) * | 2023-02-10 | 2023-04-11 | 中国药科大学 | 热疗组合物、药物组合物及其制备方法和应用 |
| IT202300023586A1 (it) * | 2023-11-08 | 2025-05-08 | Hope S R L | Composizione per prevenire e trattare patologie neurodegenerative e disturbi cognitivi |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4540884A (en) | 1982-12-29 | 1985-09-10 | Finnigan Corporation | Method of mass analyzing a sample by use of a quadrupole ion trap |
| US5397894A (en) | 1993-05-28 | 1995-03-14 | Varian Associates, Inc. | Method of high mass resolution scanning of an ion trap mass spectrometer |
| JP3415198B2 (ja) * | 1993-06-30 | 2003-06-09 | 三省製薬株式会社 | 皮膚外用剤 |
| US7112609B2 (en) | 1999-06-01 | 2006-09-26 | Drugtech Corporation | Nutritional supplements |
| US6258846B1 (en) | 1999-06-01 | 2001-07-10 | Drugtech Corporation | Nutritional supplements |
| ES2179767B1 (es) | 2001-03-16 | 2004-05-16 | Compañia General Del Algarrobo De España, S.A. | Procedimiento para la obtencion de pinitol a partir de extractos de algarroba. |
| US7521481B2 (en) * | 2003-02-27 | 2009-04-21 | Mclaurin Joanne | Methods of preventing, treating and diagnosing disorders of protein aggregation |
| EP1559430B1 (fr) * | 2004-01-29 | 2009-04-15 | INDENA S.p.A. | Utilisation de complexes de Ginkgo pour l'augmentation des fonctions cognitives et l'appaisement de la fatigue mentale |
| US8193250B2 (en) | 2004-10-22 | 2012-06-05 | Mount Sinai School Of Medicine | Compositions and methods for treating alzheimer's disease and related disorders and promoting a healthy nervous system |
| US20070032548A1 (en) | 2005-07-08 | 2007-02-08 | Ellis Lorie A | Polyunsaturated fatty acids for treatment of dementia and pre-dementia-related conditions |
| HUE041715T2 (hu) * | 2007-12-21 | 2019-05-28 | Dr Willmar Schwabe Gmbh & Co Kg | Ginkgo biloba levél-kivonat alkalmazása |
| EP2087900A1 (fr) * | 2008-02-07 | 2009-08-12 | Velleja Research SRL | Extrait de Ginkgo biloba avec un contenu de flavonoïde du ginkgo standardisé privé de la fraction terpénique à antagoniste paf, et compositions le contenant, pour la prévention et le traitement des troubles circulatoires, cognitifs, gériatriques et sensoriels |
| JP5610736B2 (ja) | 2009-10-06 | 2014-10-22 | 森永製菓株式会社 | ポリフェノール類化合物の吸収促進用の医薬組成物、ポリフェノール類化合物を含有する飲食品又は飲食品素材の製造方法及びポリフェノール類化合物を含有する飲食品又は飲食品素材 |
| EP2627326A2 (fr) * | 2010-10-12 | 2013-08-21 | Vifor SA | Nouvelles compositions contenant des acides gras oméga-3 et oméga-6 et leurs utilisations |
| US20150164833A1 (en) * | 2013-12-17 | 2015-06-18 | Mead Johnson Nutrition Company | Nutritional composition containing a neurologic component of ursolic acid and uses thereof |
| JP2017178914A (ja) | 2016-03-31 | 2017-10-05 | 株式会社ニュートリション・アクト | 脳機能改善及び向上のための組成物 |
| JP2019064955A (ja) | 2017-09-29 | 2019-04-25 | 金印株式会社 | アミロイドβ耐性増強剤 |
-
2021
- 2021-01-08 MX MX2022008258A patent/MX2022008258A/es unknown
- 2021-01-08 BR BR112022013296A patent/BR112022013296A2/pt unknown
- 2021-01-08 EP EP21700015.7A patent/EP4084787A1/fr active Pending
- 2021-01-08 JP JP2022541278A patent/JP7655920B2/ja active Active
- 2021-01-08 AU AU2021204964A patent/AU2021204964A1/en active Pending
- 2021-01-08 KR KR1020227026367A patent/KR20220123272A/ko active Pending
- 2021-01-08 CN CN202180008005.7A patent/CN115066237A/zh active Pending
- 2021-01-08 WO PCT/EP2021/050270 patent/WO2021136848A1/fr not_active Ceased
-
2022
- 2022-07-26 CO CONC2022/0010461A patent/CO2022010461A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP4084787A1 (fr) | 2022-11-09 |
| CN115066237A (zh) | 2022-09-16 |
| JP7655920B2 (ja) | 2025-04-02 |
| KR20220123272A (ko) | 2022-09-06 |
| MX2022008258A (es) | 2022-08-11 |
| BR112022013296A2 (pt) | 2022-09-06 |
| WO2021136848A1 (fr) | 2021-07-08 |
| AU2021204964A1 (en) | 2022-07-07 |
| JP2023510525A (ja) | 2023-03-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2022010461A2 (es) | Composición para usar en el tratamiento de trastornos cognitivos | |
| CL2021002099A1 (es) | Combinación farmacéutica que comprende tno155 y ribociclib. | |
| CO2019008087A2 (es) | Método para modular la actividad de inflamasoma e inflamación en el pulmón | |
| MX2021009562A (es) | Combinacion farmaceutica que comprende tno155 y un inhibidor de pd-1. | |
| CL2017001983A1 (es) | Composiciones farmacéuticas para terapia combinada. | |
| MX2018013240A (es) | Composiciones antiirritantes sinergisticas de taurina y aloe. | |
| MX2022012536A (es) | Composiciones que comprenden polisacaridos sulfatados. | |
| CL2019001658A1 (es) | Derivados de la pirimidin enona tricíclica para la inhibición de rory y otros usos. | |
| MX2020006001A (es) | Composicion para el cuidado personal. | |
| BR112021024109A2 (pt) | Composições farmacêuticas compreendendo um agonista fxr e um fibrato para uso no tratamento de doença hepática colestática | |
| BR112019018088A2 (pt) | Composições propositadamente selecionadas que compreendem canabinoides purificados e/ou terpenos purificados | |
| CL2022002833A1 (es) | Anticuerpos anti-flt3 y composiciones | |
| BR112022001968A2 (pt) | Formulações que incluem di-hidrohonokiol | |
| BR112018077350A2 (pt) | composições de fosfolipídio | |
| BR112022019432A2 (pt) | Terapia de aumento mitocondrial | |
| BR112022021402A2 (pt) | Composição sinérgica para cuidados pessoais/preservante com um éster de poliglicerol | |
| BR112023000333A2 (pt) | Composição farmacêutica para o tratamento de vitiligo | |
| BR112022022467A2 (pt) | Composições para tratamento bucal que compreendem ácido dicarboxílico | |
| CO2024017422A2 (es) | Composiciones y métodos para inhibir la expresión de serina proteasa transmembrana 6 (tmprss6) | |
| CL2019003011A1 (es) | Composiciones para el cuidado bucal a base de oxido de cinc y fosfato de dihidrógeno de calcio. | |
| BR112023025880A2 (pt) | Formulação subcutânea e métodos para tratamento de edema refratário a diuréticos orais | |
| BR112022015029A2 (pt) | Formulações que fornecem desempenho de fragrância de longa de duração | |
| MX2023007479A (es) | Composiciones de cannabidiol y usos de las mismas. | |
| BR112019003630A2 (pt) | composição oleosa para metalurgia e método para metalurgia | |
| BR112018071493A2 (pt) | usos de ácido linoleico (la) e ácido alfa-linolênico (ala) na fabricação de uma composição nutricional, composição nutricional, método para prevenir declínio no funcionamento cognitivo induzido e método para prevenir redução na neurogênese induzida por estresse precoce |